Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortNK1 antagonist for chemotherapy nausea, especially delayed vomiting.Powerful anti-sickness medicine.
Body systemStomach & GutStomach & Gut
Drug classNK1 antagonists5-HT3 antagonists
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesChemotherapy-induced nausea and vomiting, Postoperative nausea and vomitingChemotherapy and radiotherapy nausea, Nausea after surgery, Gastroenteritis vomiting (children, single dose), Severe pregnancy sickness (second line)
How it worksBlocks a brain signal that triggers delayed vomiting.Blocks serotonin signals that trigger vomiting.
Starts workingWithin hours30 minutes
Half-life9–13 hours3–6 hours
Typical adult dose125 mg 1 hour before chemotherapy on day 1, then 80 mg on days 2 and 3.4–8 mg up to three times a day (higher with chemotherapy).
FormsCapsule, IV injection (fosaprepitant)Tablet, Orodispersible tablet or film, Oral solution, Injection
Common side effectsTiredness, Constipation, Hiccups, Reduced appetiteConstipation, Headache, Warmth or flushing
Serious side effectsAllergic reactions, Liver enzyme riseQT prolongation, Serotonin syndrome with other serotonergic drugs (rare)
Don't take ifTaking pimozide; Taking cisaprideKnown long QT syndrome; Taking apomorphine; Allergy to ondansetron
AlcoholUsually no problem in moderation. No specific interaction.Usually no problem in moderation. No specific interaction.
PregnancyUse with cautionLimited data.Use with cautionA small increase in cleft palate is possible with first-trimester use; may be used if first-line options fail.
BreastfeedingUsually avoidedAvoid.Use with cautionLimited data; avoid in the first trimester unless needed.
In use since—1991
Brand namesUnited States: Emend, CinvantiUnited Kingdom: EmendIndia: Emend, Aprecap, Fosprepitant (generic)United States: ZofranUnited Kingdom: ZofranIndia: Emeset, Ondem, Vomikind
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeA04AD12A04AA01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker